Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 12 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2020Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intoleranceNicholls, S.J.; Lincoff, A.M.; Bays, H.E.; Cho, L.; Grobbee, D.E.; Kastelein, J.J.; Libby, P.; Moriarty, P.M.; Plutzky, J.; Ray, K.K.; Thompson, P.D.; Sasiela, W.; Mason, D.; McCluskey, J.; Davey, D.; Wolski, K.; Nissen, S.E.
2023Cardiovascular risk factor reporting in immune checkpoint inhibitor trials: A systematic reviewTan, S.; Sivakumar, S.; Segelov, E.; Nicholls, S.J.; Nelson, A.J.
2023Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trialGray, M.P.; Berman, Y.; Bottà, G.; Grieve, S.M.; Ho, A.; Hu, J.; Hyun, K.; Ingles, J.; Jennings, G.; Kilov, G.; Levesque, J.F.; Meikle, P.; Redfern, J.; Usherwood, T.; Vernon, S.T.; Nicholls, S.J.; Figtree, G.A.
2021Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trialVenkataraman, P.; Huynh, Q.; Nicholls, S.J.; Stanton, T.; Watts, G.F.; Marwick, T.H.
2023Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)Zoungas, S.; Curtis, A.; Spark, S.; Wolfe, R.; McNeil, J.J.; Beilin, L.; Chong, T.T.J.; Cloud, G.; Hopper, I.; Kost, A.; Nelson, M.; Nicholls, S.J.; Reid, C.M.; Ryan, J.; Tonkin, A.; Ward, S.A.; Wierzbicki, A.
2022Strengthening cardiovascular trials across Australia and New Zealand - the Alliance for Cardiovascular Trials (ANZACT) NetworkReid, C.M.; Patel, A.; Nicholls, S.J.; Briffa, T.
2022Atherosclerotic Cardiovascular Risk With Combination Avelumab and AxitinibTan, S.; Day, D.; Nicholls, S.J.; Segelov, E.
2022New Cardiovascular Risk Assessment Techniques for Primary Prevention: JACC Review Topic of the WeekVerma, K.P.; Inouye, M.; Meikle, P.J.; Nicholls, S.J.; Carrington, M.J.; Marwick, T.H.
2022Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocolMarschner, S.; Wing-Lun, E.; Chow, C.; Maple-Brown, L.; Graham, S.; Nicholls, S.J.; Brown, A.; Wood, A.; Ihdayhid, A.; Von Huben, A.; Zaman, S.
2022Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) GenotypesLacaze, P.; Bakshi, A.; Riaz, M.; Polekhina, G.; Owen, A.; Bhatia, H.S.; Natarajan, P.; Wolfe, R.; Beilin, L.; Nicholls, S.J.; Watts, G.F.; McNeil, J.J.; Tonkin, A.M.; Tsimikas, S.